These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37595583)

  • 1. Spatiotemporal cell junction assembly in human iPSC-CM models of arrhythmogenic cardiomyopathy.
    Kim SL; Trembley MA; Lee KY; Choi S; MacQueen LA; Zimmerman JF; de Wit LHC; Shani K; Henze DE; Drennan DJ; Saifee SA; Loh LJ; Liu X; Parker KK; Pu WT
    Stem Cell Reports; 2023 Sep; 18(9):1811-1826. PubMed ID: 37595583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium current abnormalities and deregulation of Wnt/β-catenin signaling in iPSC-derived cardiomyocytes generated from patient with arrhythmogenic cardiomyopathy harboring compound genetic variants in plakophilin 2 gene.
    Khudiakov A; Zaytseva A; Perepelina K; Smolina N; Pervunina T; Vasichkina E; Karpushev A; Tomilin A; Malashicheva A; Kostareva A
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165915. PubMed ID: 32768677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
    Kim C; Wong J; Wen J; Wang S; Wang C; Spiering S; Kan NG; Forcales S; Puri PL; Leone TC; Marine JE; Calkins H; Kelly DP; Judge DP; Chen HS
    Nature; 2013 Feb; 494(7435):105-10. PubMed ID: 23354045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes.
    Inoue H; Nakamura S; Higo S; Shiba M; Kohama Y; Kondo T; Kameda S; Tabata T; Okuno S; Ikeda Y; Li J; Liu L; Yamazaki S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
    Stem Cell Reports; 2022 Feb; 17(2):337-351. PubMed ID: 35063130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmogenic cardiomyopathy: An in-depth look at molecular mechanisms and clinical correlates.
    Costa S; Cerrone M; Saguner AM; Brunckhorst C; Delmar M; Duru F
    Trends Cardiovasc Med; 2021 Oct; 31(7):395-402. PubMed ID: 32738304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive Reduction in Right Ventricular Contractile Function Attributable to Altered Actin Expression in an Aging Mouse Model of Arrhythmogenic Cardiomyopathy.
    Camors EM; Roth AH; Alef JR; Sullivan RD; Johnson JN; Purevjav E; Towbin JA
    Circulation; 2022 May; 145(21):1609-1624. PubMed ID: 35437032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM).
    Janz A; Zink M; Cirnu A; Hartleb A; Albrecht C; Rost S; Klopocki E; Günther K; Edenhofer F; Ergün S; Gerull B
    Stem Cell Res; 2021 May; 53():102256. PubMed ID: 33640690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy.
    Tsui H; van Kampen SJ; Han SJ; Meraviglia V; van Ham WB; Casini S; van der Kraak P; Vink A; Yin X; Mayr M; Bossu A; Marchal GA; Monshouwer-Kloots J; Eding J; Versteeg D; de Ruiter H; Bezstarosti K; Groeneweg J; Klaasen SJ; van Laake LW; Demmers JAA; Kops GJPL; Mummery CL; van Veen TAB; Remme CA; Bellin M; van Rooij E
    Sci Transl Med; 2023 Mar; 15(688):eadd4248. PubMed ID: 36947592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene.
    Jahng JWS; Black KE; Liu L; Bae HR; Perez M; Ashley EA; Sallam K; Wu JC
    Stem Cell Res; 2021 May; 53():102284. PubMed ID: 33743362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of Ca
    Kim JC; Pérez-Hernández M; Alvarado FJ; Maurya SR; Montnach J; Yin Y; Zhang M; Lin X; Vasquez C; Heguy A; Liang FX; Woo SH; Morley GE; Rothenberg E; Lundby A; Valdivia HH; Cerrone M; Delmar M
    Circulation; 2019 Sep; 140(12):1015-1030. PubMed ID: 31315456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
    Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
    Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic Characterization of a Human In Vitro Model of Arrhythmogenic Cardiomyopathy Under Topological and Mechanical Stimuli.
    Martewicz S; Luni C; Serena E; Pavan P; Chen HV; Rampazzo A; Elvassore N
    Ann Biomed Eng; 2019 Mar; 47(3):852-865. PubMed ID: 30569242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50.
    Ermon B; Volpato CB; Cattelan G; Silipigni R; Di Segni M; Cantaloni C; Casella M; Pramstaller PP; Pompilio G; Sommariva E; Meraviglia V; Rossini A
    Stem Cell Res; 2018 Oct; 32():78-82. PubMed ID: 30219716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.
    Cerrone M; Lin X; Zhang M; Agullo-Pascual E; Pfenniger A; Chkourko Gusky H; Novelli V; Kim C; Tirasawadichai T; Judge DP; Rothenberg E; Chen HS; Napolitano C; Priori SG; Delmar M
    Circulation; 2014 Mar; 129(10):1092-103. PubMed ID: 24352520
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Lyon A; van Opbergen CJM; Delmar M; Heijman J; van Veen TAB
    Front Physiol; 2021; 12():732573. PubMed ID: 34630150
    [No Abstract]   [Full Text] [Related]  

  • 18. Recessive variants in plakophilin-2 contributes to early-onset arrhythmogenic cardiomyopathy with severe heart failure.
    Chen K; Rao M; Guo G; Duru F; Chen L; Chen X; Song J; Hu S
    Europace; 2019 Jun; 21(6):970-977. PubMed ID: 30830208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plakophilin-2 is required for transcription of genes that control calcium cycling and cardiac rhythm.
    Cerrone M; Montnach J; Lin X; Zhao YT; Zhang M; Agullo-Pascual E; Leo-Macias A; Alvarado FJ; Dolgalev I; Karathanos TV; Malkani K; Van Opbergen CJM; van Bavel JJA; Yang HQ; Vasquez C; Tester D; Fowler S; Liang F; Rothenberg E; Heguy A; Morley GE; Coetzee WA; Trayanova NA; Ackerman MJ; van Veen TAB; Valdivia HH; Delmar M
    Nat Commun; 2017 Jul; 8(1):106. PubMed ID: 28740174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding Arrhythmogenic Cardiomyopathy: Advances through the Use of Human Pluripotent Stem Cell Models.
    Chua CJ; Morrissette-McAlmon J; Tung L; Boheler KR
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.